| Mina Gamal Nasr Wilson, MD | |
|
25 Wells St, Westerly, RI 02891-2922 | |
| (860) 271-4364 | |
| Not Available |
| Full Name | Mina Gamal Nasr Wilson |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 25 Wells St, Westerly, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831612035 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD16997 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Westerly Hospital | Westerly, RI | Hospital |
| Lawrence & Memorial Hospital | New london, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospital Medicine Associates Llc | 9234156985 | 168 |
News Archive
The results of a new randomized clinical trial, published in The Lancet Global Health, have demonstrated that using fluvoxamine to treat high-risk outpatients with early-diagnosed COVID-19 reduced the need for prolonged observation in an emergency setting or hospitalization, compared to a control group who received a placebo.
Research at the University of Southern Denmark has revealed that a new combination of clinically tested drugs inhibits the growth of tumors, thereby potentially improving patients' survival.
The John Theurer Cancer Center at Hackensack University Medical Center and The Leukemia & Lymphoma Society have come together to host Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers on Tuesday, June 22 in Hackensack, NJ. This free educational program is for patients, caregivers, and healthcare providers.
An international research team led by UvA researchers Jeroen Bos, Martin Vinck and Cyriel Pennartz has identified a new type of neuron which might play a vital role in humans' ability to navigate their environments. The discovery is an important step towards understanding how the brain codes navigation behaviour at larger scales and could potentially open up new treatment strategies for people with impaired topographical orientation like Alzheimer's patients.
› Verified 5 days ago
| Entity Name | Hospital Medicine Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093758781 PECOS PAC ID: 9234156985 Enrollment ID: O20170816001446 |
News Archive
The results of a new randomized clinical trial, published in The Lancet Global Health, have demonstrated that using fluvoxamine to treat high-risk outpatients with early-diagnosed COVID-19 reduced the need for prolonged observation in an emergency setting or hospitalization, compared to a control group who received a placebo.
Research at the University of Southern Denmark has revealed that a new combination of clinically tested drugs inhibits the growth of tumors, thereby potentially improving patients' survival.
The John Theurer Cancer Center at Hackensack University Medical Center and The Leukemia & Lymphoma Society have come together to host Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers on Tuesday, June 22 in Hackensack, NJ. This free educational program is for patients, caregivers, and healthcare providers.
An international research team led by UvA researchers Jeroen Bos, Martin Vinck and Cyriel Pennartz has identified a new type of neuron which might play a vital role in humans' ability to navigate their environments. The discovery is an important step towards understanding how the brain codes navigation behaviour at larger scales and could potentially open up new treatment strategies for people with impaired topographical orientation like Alzheimer's patients.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mina Gamal Nasr Wilson, MD 25 Wells St, Westerly, RI 02891-2922 Ph: (860) 271-4364 | Mina Gamal Nasr Wilson, MD 25 Wells St, Westerly, RI 02891-2922 Ph: (860) 271-4364 |
News Archive
The results of a new randomized clinical trial, published in The Lancet Global Health, have demonstrated that using fluvoxamine to treat high-risk outpatients with early-diagnosed COVID-19 reduced the need for prolonged observation in an emergency setting or hospitalization, compared to a control group who received a placebo.
Research at the University of Southern Denmark has revealed that a new combination of clinically tested drugs inhibits the growth of tumors, thereby potentially improving patients' survival.
The John Theurer Cancer Center at Hackensack University Medical Center and The Leukemia & Lymphoma Society have come together to host Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers on Tuesday, June 22 in Hackensack, NJ. This free educational program is for patients, caregivers, and healthcare providers.
An international research team led by UvA researchers Jeroen Bos, Martin Vinck and Cyriel Pennartz has identified a new type of neuron which might play a vital role in humans' ability to navigate their environments. The discovery is an important step towards understanding how the brain codes navigation behaviour at larger scales and could potentially open up new treatment strategies for people with impaired topographical orientation like Alzheimer's patients.
› Verified 5 days ago
Rachel Mccormick, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 25 Wells St, Westerly, RI 02891 Phone: 800-933-5960 Fax: 860-444-5114 | |
George Giffault, D.O. Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 25 Wells St, Westerly, RI 02891 Phone: 800-933-5960 |